Raffaello Wilson Matthew, Henrina Joshua, Huang Ian, Lim Michael Anthonius, Suciadi Leonardo Paskah, Siswanto Bambang Budi, Pranata Raymond
Faculty of Medicine, Universitas Pelita Harapan Tangerang, Indonesia.
Siloam Heart Institute, Siloam Hospitals Kebon Jeruk Jakarta, Indonesia.
Card Fail Rev. 2021 Feb 19;7:e02. doi: 10.15420/cfr.2020.20. eCollection 2020 Mar.
Heart failure is currently one of the leading causes of morbidity and mortality. Patients with heart failure often present with acute symptoms and may have a poor prognosis. Recent evidence shows differences in clinical characteristics and outcomes between de novo heart failure (DNHF) and acute decompensated chronic heart failure (ADCHF). Based on a better understanding of the distinct pathophysiology of these two conditions, new strategies may be considered to treat heart failure patients and improve outcomes. In this review, the authors elaborate distinctions regarding the clinical characteristics and outcomes of DNHF and ADCHF and their respective pathophysiology. Future clinical trials of therapies should address the potentially different phenotypes between DNHF and ADCHF if meaningful discoveries are to be made.
心力衰竭是目前发病率和死亡率的主要原因之一。心力衰竭患者常出现急性症状,预后可能较差。最近的证据表明,新发心力衰竭(DNHF)和急性失代偿性慢性心力衰竭(ADCHF)在临床特征和预后方面存在差异。基于对这两种情况不同病理生理学的更好理解,可考虑采用新策略来治疗心力衰竭患者并改善预后。在本综述中,作者阐述了DNHF和ADCHF在临床特征、预后及其各自病理生理学方面的差异。如果要取得有意义的发现,未来的治疗临床试验应关注DNHF和ADCHF之间潜在的不同表型。